QQE WART REMOVER - Guangzhou Huixue Biotechnology Co., Ltd.

Manufacturer
Guangzhou Huixue Biotechnology Co., Ltd.
Effective date
2026-05-23
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-06-03 18:03:35

Label at a glance#

ProductQQE WART REMOVER
Active ingredientSALICYLIC ACID, CHLOROACETATE
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 40%

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

if swallowed, seek medical attention or contact a Poison Control Center (1-800-222-1222) immediately.

OTC - PURPOSE SECTION

Uses For the removal of warts, including plantar warts, flat warts, common warts, corns, and calluses.

WARNINGS SECTION

Warnings For external use only. Flammable Keep away from fire and flame. Keep out of reach of children. Avoid contact with eyes, in case of contact, flush eyes with plenty of cool water. Do not swallow

INACTIVE INGREDIENT SECTION

Water, Borneol, Glycerin, Polyethylene Glycol, Bisabolol, Allantoin, Lonicera Japonica (Honeysuckle) Flower Extract, Sophora Augustifolia Root Extract, Hyaluronic Acid, Aloe Vera Extract,Cnidium Monnieri Extract, Gentiana Scabra Root Extract, Portulaca Oleracea Extract, Zingiber Officinale (Ginger) Root Extract.

DOSAGE & ADMINISTRATION SECTION

1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional), 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry 3. Repeat this process 2-3 times daily until the skin looks smooth. 4. More severe may require more time.Patience and perseverance are required during its use. The longest continuous use period is no more than 12 weeks.

OTC - DO NOT USE SECTION

On broken skin or the area around the eyes. On irritated skin or on any area that is infected or reddened.Do not use If you are allergic to any ingredient in this product. .On moles, birthmarks, warts with hair growing from them, genital warts or warts on the face or mucous membranes. • If you have diabetes or poor blood circulation. If you are pregnant or breastfeeding ness rec y hare practitioner.

OTC - STOP USE SECTION

Discontinue use and consult a doctor if: . You become pregnant or are trying to become pregnant while using this product. Irritation or redness occurs, worsens, or does not improve with continued use.

OTC - WHEN USING SECTION

1.Clean the affected area. You can soak the affected area in warm water for 5 minutes (optional). 2. Take an appropriate amount of the solution and apply it to the affected area, making sure it covers completely. Wait for it to dry. 3. Repeat this process 2-3 times daily until the skin looks smooth.

INDICATIONS & USAGE SECTION

plantar warts, flat warts, common warts, corns, and calluses.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

QQE Fungal Nail TreatmentQQE Fungal Nail Treatment

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87204-17787204-177-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
QQE WART REMOVERSALICYLIC ACID 40%Guangzhou Huixue Biotechnology Co., Ltd.5279f8c8-09ae-8483-e063-6394a90a00e62026-05-23WarningsExact identifier
ndc (package): 87204-177-01
ndc (product): 87204-177
ndc11 (package): 87204017701
spl id: 5279f8c8-09af-8483-e063-6394a90a00e6
spl set id: 5279f8c8-09ae-8483-e063-6394a90a00e6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.